4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with sulindac sulfone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahnen, DJ; Castonguay, A; Dwyer-Nield, LD; Koski, KM; Malkinson, AM; Pamukcu, R; Piazza, GA; Rice, PL; Rioux, N; Thompson, H | 1 |
1 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and sulindac sulfone
Article | Year |
---|---|
Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone).
Topics: Animals; Antineoplastic Agents; Carcinogens; Drug Screening Assays, Antitumor; Female; Lung Neoplasms; Mice; Mice, Inbred A; Nitrosamines; Sulindac | 1998 |